Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|12|3|153-161

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.12, Iss.3, 2013-06, pp. : 153-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine Receptors As Promising Therapeutic Targets for Drug Development in Chronic Airway Inflammation

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 699-706

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets for Diabetic Nephropathy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 83-92

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic Targets

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 42-50

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine and Adenosine Receptors: Their Contribution to Airway Inflammation and Therapeutic Potential in Asthma

By  

Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-10 ,pp. : 3875-3885

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of new therapeutic targets for prevention of CNS inflammation

By Owens Trevor  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 2, 2002-04 ,pp. : 203-215

Informa Healthcare

Access to resources Recommend Favorite